Sort
15,273 grants matching “antimicrobial resistance”
Antibiotic Resistance Surveillance in Retail Meat Samples from South Dakota and North Dakota
$129,000Alan Kenneth Erickson · South Dakota State University · U01 · FY2017 · FD
Tau-binding B Cells in Alzheimer's Disease
$128,965Thomas L Rothstein · Feinstein Institute For Medical Research · R21 · FY2016 · AG
Collaborative Research: Linking Pharmacokinetics to Epidemiological Models of Vector-Borne Diseases and Drug Resistance Prevention
$128,903Gregery T Buzzard · Purdue University · · FY2018 · MPS
PROOF OF CONCEPT FOR ANTIMICROBIAL PROPERTIES OF LACRITIN IN VIVO
$128,842John D Sheppard · Eyerx Research, Inc. · R41 · FY2010 · EY
Clinical and Molecular Epidemiology of Multidrug-Resistant Organisms in a Communi
$128,817Deverick John Anderson · Duke University · K23 · FY2012 · AI
Clinical and Molecular Epidemiology of Multidrug-Resistant Organisms in a Communi
$128,817Deverick John Anderson · Duke University · K23 · FY2015 · AI
Clinical and Molecular Epidemiology of Multidrug-Resistant Organisms in a Communi
$128,817Deverick John Anderson · Duke University · K23 · FY2014 · AI
Clinical and Molecular Epidemiology of Multidrug-Resistant Organisms in a Communi
$128,817Deverick John Anderson · Duke University · K23 · FY2011 · AI
Colistimethate Dose Optimization in Infants and Children
$128,756John S Bradley · University Of California, San Diego · U54 · FY2015 · HD
Dissecting the means by which type 3 substrates are defined & secreted
$128,727Cammie Lesser · Massachusetts General Hospital · R01 · FY2022 · AI
Short-term biomedical research training program for veterinary students
$128,656Vilma Yuzbasiyan-Gurkan · Michigan State University · T35 · FY2021 · OD
Vaccine and Treatment Evaluation Units: Concept and Protocol Development
$128,378Susanna Naggie · Duke University · N01 · FY2017 · AI
Defining Precursors to VRSA Emergence: Epidemiology of MRSA & VRE Dual Infection
$128,321Emily Toth Martin · University Of Michigan At Ann Arbor · K01 · FY2014 · AI
Defining Precursors to VRSA Emergence: Epidemiology of MRSA & VRE Dual Infection
$128,321Emily Toth Martin · Wayne State University · K01 · FY2013 · AI
Defining Precursors to VRSA Emergence: Epidemiology of MRSA & VRE Dual Infection
$128,321Emily Toth Martin · Wayne State University · K01 · FY2012 · AI
Defining Precursors to VRSA Emergence: Epidemiology of MRSA & VRE Dual Infection
$128,321Emily Toth Martin · University Of Michigan At Ann Arbor · K01 · FY2015 · AI
Parasite Drug Susceptibility in The Response To Anti-Leishmanial Treatment
$128,300Nancy Gore Saravia · Centro Internacional (Cideim) · U19 · FY2020 · AI
Characterizing novel Beta-lactamases from metagenomic samples: insights into the evolution of antimicrobial resistance from the environment towards human-associated pathogens
$128,258Pablo Power · Ubatec S.A. · R01 · FY2024 · AI
Metabolomics Evaluation of the Etiology of Pneumonia
$128,250Lilliam Ambroggio · University Of Colorado Denver · K01 · FY2021 · AI
Device use in Nursing Homes: Reducing Risk of Infection
$128,250University Of Michigan At Ann Arbor · K23 · FY2004 · AG
Chlorhexidine and Pneumonia in Nursing Home Residents
$128,250Catherine J Binkley · University Of Louisville · K23 · FY2007 · DE
Pharmacokinetic-Pharmacodynamics of Antimicrobials in Resistant Infections
$128,250Jennifer Le · University Of California, San Diego · K23 · FY2014 · AI
Pharmacokinetic-Pharmacodynamics of Antimicrobials in Resistant Infections
$128,250Jennifer Le · University Of California, San Diego · K23 · FY2013 · AI
Device use in Nursing Homes: Reducing Risk of Infection
$128,250University Of Michigan At Ann Arbor · K23 · FY2003 · AG
Pharmacokinetic-Pharmacodynamics of Antimicrobials in Resistant Infections
$128,250Jennifer Le · University Of California, San Diego · K23 · FY2010 · AI